Maternal serum fatty acid binding protein‐4 level is upregulated in fetal growth restriction with abnormal Doppler flow patterns

Abstract

AbstractPurposeThis study aimed to determine fatty acid binding protein‐4 (FABP‐4) concentrations in maternal serum of fetal growth restriction (FGR) pregnancies and controls of normal pregnancies. Furthermore, we hypothesized that the alterations in FABP‐4 levels might correlate with FGR severity.MethodsWe performed this prospective case–control study with 83 pregnant women. The study groups included 26 FGR pregnancies without abnormal fetal Doppler flow patterns and 25 pregnancies complicated with FGR accompanied by abnormal fetal Doppler flow patterns.ResultsThe median serum FABP‐4 concentrations were significantly higher in the FGR cases with abnormal Doppler flow pattern group (2.09 ng/mL) than in the FGR cases without abnormal Doppler flow pattern group (1.62 ng/mL) and the control group (1.20 ng/mL, p < 0.001). A significant negative correlation was observed between maternal serum FABP‐4 levels and time to birth from blood sample collection (r = −0.356 and p = 0.001), gestational week at birth (r = −0.386 and p < 0.001), and birth weight (r = −0.394 and p < 0.001). A 1.35 ng/mL cut‐off value of serum FABP‐4 level could be used to discriminate FGR cases with a 78.4% sensitivity and 60.6% specificity. The optimal cut‐off value of FABP‐4 levels as an indicator for the diagnosis of FGR with abnormal Doppler flow pattern was estimated to be 1.76 ng/mL, which yielded a sensitivity of 84.0% and a specificity of 75.8%.ConclusionFABP‐4 is a crucial biomarker in the diagnosis and determining the severity of pregnancies with restricted fetal growth. We consider that FABP‐4 is a powerful, reliable, and unique biomarker to diagnose FGR pregnancies.